ACC 2022: Sodium Thiosulfate Fails to Reduce Myocardial Injury in STEMI Patients
The small infarct sizes observed in the trial may have contributed to the lack of observed effect, suggested an expert
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.